Sign in

CIK 0001626971

  • Non-accelerated filer
  • Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464670809
Phone
+1 650-900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market buy 10% owner bought 1,176,470 shares at $8.50 ($9,999,995)
  2. 4 Open-market buy Director bought 588,235 shares at $8.50 ($4,999,998)
  3. 4 Open-market buy 10% owner bought 588,235 shares at $8.50 ($4,999,998)
  4. 4 Open-market buy President and CEO bought 100,000 shares at $8.50 ($850,000)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy President and CEO bought 10,000 shares at $10.79 ($107,850)
  14. 4 Open-market buy 10% owner bought 20,000 shares at $10.95 ($219,000)
  15. 4 Open-market buy President and CEO bought 25,000 shares at an average $9.88 ($247,084)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 13 · 252 filings